loader
Please Wait
Applying Filters...

Looking for Pharmaceutical Excipients offered by Gangwal Chemicals? Find Crospovidone based excipient solutions to address drug delivery challenges on PharmaCompass.

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10Gangwal Chemicals

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

02

arrow
CPhI India 2024
Not Confirmed
arrow
CPhI India 2024
Not Confirmed

Brand Name : POLYKOVIDONE

Excipient Details : Super disintegrate, solublity enhancer, Suspension stabilizer, Complexing agent, Low peroxide content, Long term stability

Pharmacopoeia Ref :

Technical Specs : Crospovidone (Type-A/B)- USP-NF / Ph. Eur. / BP / IP

Grade : Oral

arrow

Brand : POLYKOVIDONE

Applications : Super disintegrate, solublity enhancer, Suspension stabilizer, Complexing agent, Low peroxide content, Long term stability

Pharmacopoeia Ref : Not Available

Technical Specs : Crospovidone (Type-A/B)- USP-NF / Ph. Eur. / BP / IP

Grade : Oral

arrow
blank

03

arrow
CPhI India 2024
Not Confirmed
arrow
CPhI India 2024
Not Confirmed

Brand : F-MELT TYPE M

Applications : F-Melt Type M is used in various dosage forms like orally disintegrating tablets (ODTs), sachets, dispersible tablets, chewable tablets and sublingual formulations.

Pharmacopoeia Ref : Conforms to Japanese Pharmaceutical Excipients. All components meet USP-NF, JP and EP.

Technical Specs : Not Available

Grade : Oral

arrow
blank

04

arrow
CPhI India 2024
Not Confirmed
arrow
CPhI India 2024
Not Confirmed

Brand : F-MELT TYPE C

Applications : F-Melt Type C is a pharmaceutical excipient used in oral dosage forms like orally disintegrating tablets, sachets, dispersible tablets, chewable tablets and sublingual tablets.

Pharmacopoeia Ref : Conforms to Japanese Pharmaceutical Excipients. All components meet USP-NF, JP, EP. US DMF Type IV filed.

Technical Specs : Not Available

Grade : Oral

arrow
blank

05

arrow
CPhI India 2024
Not Confirmed
arrow
CPhI India 2024
Not Confirmed
blank